2023 Was a tricky year for that biopharma business, with various businesses downsizing and restructuring their workforces to stay afloat. There are signs of recovery, as mergers and acquisitions picked up across the pharmaceutical and existence sciences sector from the latter Element of 2023 and possess ongoing their upswing into https://sites.google.com/view/bio-sites/blog